| Catalog_no |
ADMC0376 |
| Product_name |
LCL-161 |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
1780.00/5560.00/8220.00 |
| Specificity |
Target: IAP. Fields: LCL161 is an oral small molecule antagonist of Apoptosis Proteins (IAPs) that sensitizes a subset of tumors from diverse lineages to treatment with cytotoxic therapies. IC50: 35 nM (XIAP, in HEK293 cell), 0.40 nM (cIAP1, in MDA- |
| Dilution |
IC50: 35 nM (XIAP, in HEK293 cell), 0.40 nM (cIAP1, in MDA-MB-231)[1] |
| Purification |
>98% |
| Concentration |
靶点：IAP;IC50： 35 nM (XIAP, in HEK293 cell), 0.40 nM (cIAP1, in MDA-MB-231)[1] |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
LCL-161; LCL161 |
| Molecular Weight |
500.63 |
| Notes |
LCL161 is an oral small molecule antagonist of Apoptosis Proteins (IAPs) that sensitizes a subset of tumors from diverse lineages to treatment with cytotoxic therapies. IC50: 35 nM (XIAP, in HEK293 cell), 0.40 nM (cIAP1, in MDA-MB-231)[1] |
| Instructions |
 查看与下载 |
